Abstract

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2021 - Volume 25, Number 5

Page(s): 415

Download in electronic PDF format for $75
  • Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Page 1

Abstract

A formulation for preparing Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • dapsone
  • sulphone antibiotic
  • formulation
  • oral suspension
  • leprosy
  • pneumocystis pneumonia
  • malaria
  • dermatitis herpetiformis
  • dermatoses
  • acne
  • toxoplasmosis
  • actinomycetoma

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2021
Pg. 415
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 491
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2006
Pg. 300
Dapsone 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 235
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
Jan/Feb 2023
Pg. 52
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Sep/Oct 2024
Pg. 408-412
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF
Author(s): Friciu Mihaela, Cull Erica, Leclair Grégoire
May/Jun 2003
Pg. 233-239
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Author(s): Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
Jul/Aug 2021
Pg. 325
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2017
Pg. 494
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 54
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 337-339
Stability of Prednisone in Oral Mix Suspending Vehicle
Author(s): Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
May/Jun 2021
Pg. 235
Temozolomide 10 mg/mL in Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 497
Prednisone 5 mg/mL ir Oral Mix Suspension
Author(s): Allen Loyd V Jr